a 2019

Dysregulated expression of lncRNAs in glioblastoma multiforme and their association with overall survival

VEČEŘA, Marek, Jan OPPELT, Lenka RADOVÁ, Radim LIPINA, S. REGULI et. al.

Basic information

Original name

Dysregulated expression of lncRNAs in glioblastoma multiforme and their association with overall survival

Authors

VEČEŘA, Marek (703 Slovakia, belonging to the institution), Jan OPPELT (203 Czech Republic, belonging to the institution), Lenka RADOVÁ (203 Czech Republic, belonging to the institution), Radim LIPINA (203 Czech Republic, belonging to the institution), S. REGULI, Martin SMRČKA (203 Czech Republic, belonging to the institution), R. JANCALEK, M. FILIP, M. HERMANOVA, L. KREN, Jiří ŠÁNA (203 Czech Republic, belonging to the institution), Alena KOPKOVÁ (203 Czech Republic, belonging to the institution), Júlia BOHOŠOVÁ (703 Slovakia, belonging to the institution) and Ondřej SLABÝ (203 Czech Republic, guarantor, belonging to the institution)

Edition

Annual Meeting of the American-Association-for-Cancer-Research (AACR), 2019

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

30204 Oncology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

RIV identification code

RIV/00216224:14740/19:00108217

Organization unit

Central European Institute of Technology

UT WoS

000488279402481

Keywords in English

lncRNAs; glioblastoma

Tags

Tags

International impact
Změněno: 3/4/2020 19:53, Mgr. Pavla Foltynová, Ph.D.

Abstract

V originále

Glioblastoma multiforme (GBM) is the most frequent primary brain malignancy of astrocytic origin. The prognosis remains very poor with the median overall survival (OS) being between 12 and 16 months from diagnosis despite early use of conventional medical therapy. Identifying new therapeutic targets, as well as prognostic and predictive biomarkers for accurate stratification of patients is therefore of utmost importance. Long non-coding RNAs (lncRNAs) are regulators of gene expression having critical impact on both physiological processes and the molecular pathology of GBM, indicating their potential as biomarkers and therapeutic targets.

Links

GA17-17636S, research and development project
Name: Identifikace nových prognostických markerů a terapeutických cílových molekul u sarkomu měkkých tkání
Investor: Czech Science Foundation
LQ1601, research and development project
Name: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
NV18-03-00398, research and development project
Name: Rozšíření současných prognostických skórovacích systémů u mozkových metastáz o mikroRNA profilování s cílem individualizace pooperační péče
Investor: Ministry of Health of the CR, Extension of established prognostic scores in brain metastases by microRNA profiling to tailor the post-operative personalized care